|
|
|
|
Trial | Studied trt | Control trt | patients | tags | ROB | Trial result | cardiovascular events | Cardiovascular death |
---|
|
Stafford , 2011 NCT | sitagliptin | | | | | - | | |
Reasner, 2011 NCT | sitagliptin | control (add on MET) | | | | - | | |
Arechavaleta, 2011 NCT | sitagliptin | glimepiride (add on MET) | | | Low risk of bias | - | | |
Aschner, 2010 NCT | sitagliptin monotherapy | metformin | | | Low risk of bias | - | | |
Derosa , 2010 | sitagliptin+pio | metformin+pio | | | | - | | |
Goldstein, 2007 NCT | sitagliptin | placebo | | | | negative | | |
Hanefeld, 2007 | sitagliptin | placebo | | | | negative | | |
TECOS, 2015 NCT | sitagliptin | placebo | | | Low risk of bias | negative | | |
Scott* (sit vs pbo), 2007 | sitagliptin 50mg bid monotherapy | placebo | | | | negative | | |
Aschner, 2006 NCT | sitagliptin monotherapy | placebo | | | | negative | | |
Nonaka, 2008 NCT | sitagliptin monotherapy | placebo | | | Low risk of bias | negative | | |
Raz, 2006 | sitagliptin monotherapy | placebo | | | | negative | | |
Barzilai, 2011 NCT | sitagliptin monotherapy | placebo | | | Low risk of bias | - | | |
Mohan , 2009 | sitagliptin monotherapy | placebo | | | Low risk of bias | - | | |
Chan, 2008 | sitagliptin monotherapy | placebo | | | Low risk of bias | - | | |
Vilsbøll, 2010 NCT | sitagliptin | placebo (add on insulin+/-MET) | | | Low risk of bias | - | | |
Charbonnel, 2006 NCT | sitagliptin | placebo (add on MET) | | | | negative | | |
Nauck, 2007 NCT | sitagliptin | placebo (add on MET) | | | | negative | | |
Scott** (sit vs pbo on top met), 2007 | sitagliptin | placebo (add on MET) | | | | negative | | |
raz, 2008 NCT | sitagliptin | placebo (add on MET) | | | | - | | |
Rosenstock , 2006 NCT | sitagliptin | placebo (add on PIO) | | | Low risk of bias | - | | |
Rosenstock (sit on top pio vs pbo), 2006 NCT | sitagliptin | placebo (on top PIO) | | | | suggesting | | |
Hermansen, 2007 | sitagliptin | placebo (on-top glimepiride+/- metformine) | | | | negative | | |
Rigby , 2010 | sitagliptin | rosiglitazone (add on MET) | | | | - | | |
Al Sifri, 2011 | sitagliptin | Sulphonylurea (on top MET) | | | | - | | |
Iwamoto , 2010 | sitagliptin monotherapy | voglibose | | | Low risk of bias | - | | |
Scott* (sit vs glipi), 2007 | sitagliptin 50mg bid monotherapy | glipizide | | | Low risk of bias | - | | |
Goldstein (sit vs met), 2007 | sitagliptin | metformin | | | | - | | |
Goldstein (sit+met vs met), 2007 | sitagliptin | metformin | | | | - | | |
Pérez-Monteverde, 2011 NCT | sitagliptin | pioglitazone | | | Low risk of bias | - | | |